BLTE   $82.46  -0.08% Market Closed

Belite Bio Inc
Total Cash
totalCashPerShare
EBITDA -36.54M
Total Debt 0.00
quickRatio
currentRatio 29.674
Total Revenue
debtToEquity
Revenue/Share
ROA -0.25621
ROE -0.41442
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue
forwardPE -84.458336
floatShares 12.67M
sharesOutstanding 30.61M
sharesShort 270.59K
sharesShortPriorMonth 280.36K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.59%
heldPercentInstitutions 0.01%
Short Ratio help_outline 6.93%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 3.743
Price To Book help_outline 21.66
earningsQuarterlyGrowth
netIncomeToCommon -35.29M
trailingEps -1.23%
forwardEps -0.96%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.29 3Q 2024
institutionsCount 19
lastUpdated Nov. 7, 2024, 1:13 p.m.